mhurhangee/ep-ind-claims huggingface dataset:
A method for producing generally uniform TiO 2 nanoparticle spheres of from 20 nm to 100 nm in size wherein each particle contains generally uniform pores in the mesopore size range having a generally narrow pore size distribution centered at a value between about 2 nm to about 12 nm and an inter-particle pore size distribution centered at a value between about 15 nm and about 80 nm, wherein the TiO 2 is at least 95 percent anatase phase with a crystallite size in the range of from about 4 nm to about 12 nm; the method comprising: (i) forming an aqueous solution of a water soluble compound of titanium at a concentration of from 0.5 to 1.5 moles per liter in the presence of an alpha hydroxyl carboxylic acid at an acid to titanium molar ratio of from 0.02 to 0.2; (ii) heating the aqueous solution in a heated reactor equipped with a condenser to a temperature in the range of from 70°C to 80°C and adding anatase TiO 2 seeds to the solution at a seed to TiO 2 molar ratio of from 0.0005 to 0.0015 while maintaining the same solution temperature for a period of from 1 hour to 3 hours, and then heating the aqueous solution to a temperature in the range of from 100°C up to the refluxing temperature and maintaining that temperature for an additional period of from 2 hours to 4 hours; (iii) cooling the solution to room or ambient temperature, and separating the reaction product. (i) forming an aqueous solution of a water soluble compound of titanium at a concentration of from 0.5 to 1.5 moles per liter in the presence of an alpha hydroxyl carboxylic acid at an acid to titanium molar ratio of from 0.02 to 0.2; (ii) heating the aqueous solution in a heated reactor equipped with a condenser to a temperature in the range of from 70°C to 80°C and adding anatase TiO 2 seeds to the solution at a seed to TiO 2 molar ratio of from 0.0005 to 0.0015 while maintaining the same solution temperature for a period of from 1 hour to 3 hours, and then heating the aqueous solution to a temperature in the range of from 100°C up to the refluxing temperature and maintaining that temperature for an additional period of from 2 hours to 4 hours; (iii) cooling the solution to room or ambient temperature, and separating the reaction product.
A roller blind comprising: a raising/lowering mechanism comprising a main body portion, a rotatable output member to which, in use, a roller-engaging stub axle can be operatively connected to effect rotation, in use, of an attached roller, a rotatable input shaft geared to the rotatable output member such that, in use, rotation of the input shaft causes the rotatable output member to rotate, wherein the rotatable output member is accessible from opposite sides of the main body portion to permit, in use, the roller-engaging stub axle to be operatively connected thereto from either side of the mechanism; and characterised by: a mounting bracket comprising a pair of cut-outs for locating the input shaft from either above or below. a raising/lowering mechanism comprising a main body portion, a rotatable output member to which, in use, a roller-engaging stub axle can be operatively connected to effect rotation, in use, of an attached roller, a rotatable input shaft geared to the rotatable output member such that, in use, rotation of the input shaft causes the rotatable output member to rotate, wherein the rotatable output member is accessible from opposite sides of the main body portion to permit, in use, the roller-engaging stub axle to be operatively connected thereto from either side of the mechanism; and characterised by: a mounting bracket comprising a pair of cut-outs for locating the input shaft from either above or below. a mounting bracket comprising a pair of cut-outs for locating the input shaft from either above or below.
An antibody against IL-1 beta, comprising the variable heavy chain CDR sequences CDR-H1, CDR-H2 or CDR-H3 as set forth in SEQ ID Nos.: 1, 2 and 3, respectively; and the variable light chain CDR sequences CDR-L1, CDR-L2 or CDR-L3 as set forth in SEQ ID Nos.: 4, 5, and 6, respectively.
A diaryl amine antioxidant of formula I, IIa and/or III: wherein each R is independently selected from the group consisting of H, C 1-16 alkyl or C 7-12 aralkyl; each G is independently H or C 1-16 alkyl, with the proviso that in formula I and formula III at least one G is a group of formula IV wherein in formula IV and formula IIa R 1 is C 1-6 alkyl and R 2 is C 1-12 alkyl, wherein the total number of carbon atoms in R 1 and R 2 combined is from 2 to 12 with the proviso that neither of R 1 and R 2 is tertiary alkyl.
A compound having structural formula I: or a pharmaceutically acceptable salt thereof, wherein: each of R 1, R 2 and R 3 is independently selected from -CH 3 and -CD 3; each of Y 1a, Y 1b, Y 2a, Y 2b, Y 3a, Y 3b, Y 4a, Y 4b, Y 4c and Y 4d is independently selected from hydrogen and deuterium; and when each of R 1, R 2 and R 3 is -CH 3, at least one of Y 1a, Y 1b, Y 2a, Y 2b, Y 3a, and Y 3b is deuterium. each of R 1, R 2 and R 3 is independently selected from -CH 3 and -CD 3; each of Y 1a, Y 1b, Y 2a, Y 2b, Y 3a, Y 3b, Y 4a, Y 4b, Y 4c and Y 4d is independently selected from hydrogen and deuterium; and when each of R 1, R 2 and R 3 is -CH 3, at least one of Y 1a, Y 1b, Y 2a, Y 2b, Y 3a, and Y 3b is deuterium.
A resin composition comprising: a polyimide resin containing 60 mol% or more of a diamine residue having a structure represented by General Formula below in all diamine residues; a thermosetting resin; and a thermally conductive filler, wherein the resin composition contains 60 parts by volume or more of the thermally conductive filler in 100 parts by volume of a total of the polyimide resin, the thermosetting resin, and the thermally conductive filler: wherein R 1 to R 4 may each be same or different and represent an alkyl group having 1 to 30 carbon atoms, a phenyl group, or a phenoxy group, and the phenyl group and the phenoxy group may be substituted with an alkyl group having 1 to 30 carbon atoms; m R 1 s and R 3 s may each be same or different; R 5 and R 6 may each be same or different and represent an alkylene group having 1 to 30 carbon atoms or an arylene group, and the arylene group may be substituted with an alkyl group having 1 to 30 carbon atoms; and m represents a range of 10 or more, and wherein the resin composition contains 15 parts by weight or less of the thermosetting resin relative to 100 parts by weight of the polyimide resin. a polyimide resin containing 60 mol% or more of a diamine residue having a structure represented by General Formula below in all diamine residues; a thermosetting resin; and a thermally conductive filler, the resin composition contains 60 parts by volume or more of the thermally conductive filler in 100 parts by volume of a total of the polyimide resin, the thermosetting resin, and the thermally conductive filler: wherein R 1 to R 4 may each be same or different and represent an alkyl group having 1 to 30 carbon atoms, a phenyl group, or a phenoxy group, and the phenyl group and the phenoxy group may be substituted with an alkyl group having 1 to 30 carbon atoms; m R 1 s and R 3 s may each be same or different; R 5 and R 6 may each be same or different and represent an alkylene group having 1 to 30 carbon atoms or an arylene group, and the arylene group may be substituted with an alkyl group having 1 to 30 carbon atoms; and m represents a range of 10 or more, and wherein the resin composition contains 15 parts by weight or less of the thermosetting resin relative to 100 parts by weight of the polyimide resin.
A pharmaceutical composition for use in the therapeutic treatment or prevention of alopecia, comprising an NADPH oxidase inhibitor, wherein the alopecia is in individuals having Col17A1 degradation.
Cutter disc comprising: - a disc-shaped support body, equipped with two faces delimited peripherally by an outer perimeter edge and centrally by a through hole for coupling with a chuck of a tool-holder; and - a plurality of teeth distributed along said outer perimeter edge; wherein each of the faces of said support body comprises at least one intermediate area having a plurality of discrete protuberances distributed radially and circumferentially and separated from one another by a recessed network of intercommunicating channels which can guide a cooling fluid released on the faces of said support body towards the teeth of said cutter, said cooling fluid being able to substantially reach each of the teeth of said cutter regardless of the number and distribution of said teeth along said outer perimeter edge, characterised in that the protuberances are integral with the support body and are made of the same material as said support body. - a disc-shaped support body, equipped with two faces delimited peripherally by an outer perimeter edge and centrally by a through hole for coupling with a chuck of a tool-holder; and - a plurality of teeth distributed along said outer perimeter edge; wherein each of the faces of said support body comprises at least one intermediate area having a plurality of discrete protuberances distributed radially and circumferentially and separated from one another by a recessed network of intercommunicating channels which can guide a cooling fluid released on the faces of said support body towards the teeth of said cutter, said cooling fluid being able to substantially reach each of the teeth of said cutter regardless of the number and distribution of said teeth along said outer perimeter edge,
A method of wireless communication of a user equipment, UE, comprising: receiving, from a second base station, an indication of resources for detecting a first base station; receiving synchronization signals and an information block from the first base station, the information block comprising information indicating whether the first base station is in a dormant state or an active state, wherein the synchronization signals and the information block are received in the resources indicated by the second base station; and detecting the first base station based on the received synchronization signals and on the information indicating whether the first base station is in the dormant state or the active state. receiving, from a second base station, an indication of resources for detecting a first base station; receiving synchronization signals and an information block from the first base station, the information block comprising information indicating whether the first base station is in a dormant state or an active state, wherein the synchronization signals and the information block are received in the resources indicated by the second base station; and detecting the first base station based on the received synchronization signals and on the information indicating whether the first base station is in the dormant state or the active state.
A method for use in determining an oedema indicator, the method including, in a processing system: a) determining at least one impedance value, representing the impedance of at least a segment of the subject, the at least one impedance value including: i) a first measured impedance value representing the impedance of an unaffected limb; ii) a second measured impedance value representing the impedance of an affected limb; b) determining the oedema indicator indicative of a subject parameter using the at least one impedance value and a reference; and c) displaying a representation of the oedema indicator; characterised in that the oedema indicator is scaled relative to the reference by: i) determining an impedance ratio using the first and second measured impedance values a. determining a mean impedance ratio value for a normal population; b. determining a three standard deviation value for the normal population; and, ii) determining the oedema indicator by scaling the impedance ratio using the mean and three standard deviation values using the equation: L - Dex = sf × IR - μ 3 ⁢ σ - μ where: L-Dex is the oedema indicator IR is the impedance ratio μ is the mean impedance ratio value for a normal population 3 σ is the three standard deviation value for the normal population sf is the scaling factor. a) determining at least one impedance value, representing the impedance of at least a segment of the subject, the at least one impedance value including: i) a first measured impedance value representing the impedance of an unaffected limb; ii) a second measured impedance value representing the impedance of an affected limb; i) a first measured impedance value representing the impedance of an unaffected limb; ii) a second measured impedance value representing the impedance of an affected limb; b) determining the oedema indicator indicative of a subject parameter using the at least one impedance value and a reference; and c) displaying a representation of the oedema indicator; i) determining an impedance ratio using the first and second measured impedance values a. determining a mean impedance ratio value for a normal population; b. determining a three standard deviation value for the normal population; and, a. determining a mean impedance ratio value for a normal population; b. determining a three standard deviation value for the normal population; and, ii) determining the oedema indicator by scaling the impedance ratio using the mean and three standard deviation values using the equation: L - Dex = sf × IR - μ 3 ⁢ σ - μ where: L-Dex is the oedema indicator IR is the impedance ratio μ is the mean impedance ratio value for a normal population 3 σ is the three standard deviation value for the normal population sf is the scaling factor. L-Dex is the oedema indicator IR is the impedance ratio μ is the mean impedance ratio value for a normal population 3 σ is the three standard deviation value for the normal population sf is the scaling factor.
A high-voltage insulator arrangement, comprising: a high-voltage insulator for insulation of a conductor of a DC gas- insulated electrical system, the insulator comprising an insulator body and an insulator surface, wherein the electrical conductivity of the insulator surface is higher than the electrical conductivity of the insulator body; and a contacting element, wherein the contacting element comprises an insulator side face having a first height (hres) for electrically connecting a predetermined length of the insulator surface to a definite potential, the contacting element further extending by a total width (w) in a width direction away from the insulator surface up to an end face, wherein a second height (hend) of the contacting element at the end face is lower than the first height (hres), wherein the height of the contacting element from the first height (hres) to the second height (hend) reduces at a gradient angle (α) such that a gas side face of the contacting element, which joins the insulator side face to the end face and which is configured to be exposed to the insulation gas, is slanted. a high-voltage insulator for insulation of a conductor of a DC gas- insulated electrical system, the insulator comprising an insulator body and an insulator surface, wherein the electrical conductivity of the insulator surface is higher than the electrical conductivity of the insulator body; and a contacting element,
A wind turbine rotor comprising: a hub, and; at least one blade supported by said hub, wherein said blade comprises a first blade section and a second blade section, said first blade section being mounted to said hub stationary with respect to said hub, said second blade section being supported by said first blade section rotatably adjustable about a longitudinal axis of said blade, wherein said second blade section is supported by the first blade section by at least two bearings (7a, 7b) which are spaced with respect the longitudinal axis of said blade. a hub, and; at least one blade supported by said hub, wherein said blade comprises a first blade section and a second blade section, said first blade section being mounted to said hub stationary with respect to said hub, said second blade section being supported by said first blade section rotatably adjustable about a longitudinal axis of said blade, wherein said second blade section is supported by the first blade section by at least two bearings (7a, 7b) which are spaced with respect the longitudinal axis of said blade.
Controlling device for navigating through a menu structure of a plurality of menu bullets (11, 12, 13; 21, 22, 23; 31, 32, 33) being arranged in a three-dimensional virtual reality on a display device, the controlling device comprising: a receiving unit being adapted for receiving a user's intention for three-dimensional menu navigation starting from a point of view of a user onto a present menu bullet to a target menu bullet, a computing unit being adapted for computing an illustration of the menu structure seen from a point of view of the user onto the target menu bullet, a display interface unit being adapted for outputting a computation result of the illustration of the menu structure seen from a point of view of the user onto the target menu bullet to a display device and a remote control being connected to the receiving unit, wherein the remote control comprises input terminals (110, 120, 130) for inputting navigation commands representing the user's intention for three-dimensional menu navigation, wherein the remote control comprises a motion sensor arrangement being connected to the input terminals, wherein the motion sensor arrangement is adapted to detect a user's motion representing the user's intention and the remote control is gripping free body attachable to the user's body, so as to follow a user's body part motion, to which user's body part the remote control is to be attached. a receiving unit being adapted for receiving a user's intention for three-dimensional menu navigation starting from a point of view of a user onto a present menu bullet to a target menu bullet, a computing unit being adapted for computing an illustration of the menu structure seen from a point of view of the user onto the target menu bullet, a display interface unit being adapted for outputting a computation result of the illustration of the menu structure seen from a point of view of the user onto the target menu bullet to a display device and a remote control being connected to the receiving unit, wherein the remote control comprises input terminals (110, 120, 130) for inputting navigation commands representing the user's intention for three-dimensional menu navigation, wherein the remote control comprises a motion sensor arrangement being connected to the input terminals, wherein the motion sensor arrangement is adapted to detect a user's motion representing the user's intention and the remote control is gripping free body attachable to the user's body, so as to follow a user's body part motion, to which user's body part the remote control is to be attached.
Hotplate device, in particular induction hotplate device, having at least one base body (13a-b), at least one first support unit (31a-b, 33a-b, 35b, 37b), at least one first heating element (20a-25a; 20b-27b), which is mounted on the first support unit (31a-b, 33a-b, 35b, 37b), at least one first actuator unit (32a-b, 34a-b, 36b, 38b) which is provided to move at least the first heating element (20a-25a; 20b-27b) with respect to the first support unit (31a-b, 33a-b, 35b, 37b), having a control unit (16a-b) and having at least one second actuator unit (30a-b), which is provided to move at least the first support unit (31a-b, 33a-b, 35b, 37b) with respect to the base body (13a-b), characterised by at least one second heating element (20a-25a; 20b-27b), which is mounted on the first support unit (31a-b, 33a-b, 35b, 37b) and is provided to be moved at least by the first actuator unit (32a-b, 34a-b, 36b, 38b) independently of the first heating element (20a-25a, 20b-27b).
An azo dye composition, comprising: an azo dye compound represented by the following Formula; and a urea compound represented by the following Formula; wherein, in Formula, R 11, R 12, R 13 and R 14 each independently represent a hydrogen atom, a halogen atom, or an aliphatic group; and R 15 represents an aliphatic group; and wherein, in Formula, R 21 and R 22 each independently represent a hydrogen atom, an aliphatic group, or an aromatic group; and n represents an integer from 0 to 2. an azo dye compound represented by the following Formula; and a urea compound represented by the following Formula; wherein, in Formula, R 11, R 12, R 13 and R 14 each independently represent a hydrogen atom, a halogen atom, or an aliphatic group; and R 15 represents an aliphatic group; and wherein, in Formula, R 21 and R 22 each independently represent a hydrogen atom, an aliphatic group, or an aromatic group; and n represents an integer from 0 to 2.
A method of analysing a sample including a bacterium of interest, the method including: exposing the sample to an antibiotic; after exposing the sample to the antibiotic, applying an absorption-based spectroscopic technique to the sample to obtain spectrum data whose spectral profile has been influenced by exposing the sample to the antibiotic, wherein applying the absorption-based spectroscopic technique to the sample includes irradiating the sample with UV-Vis radiation having a wavelength in the range 200nm to 800 nm; obtaining information regarding the susceptibility/resistance of the bacterium of interest to the antibiotic from the spectrum data; wherein the absorption-based spectroscopic technique is applied to the sample no more than 60 minutes after the initial exposure of the sample to the antibiotic. exposing the sample to an antibiotic; after exposing the sample to the antibiotic, applying an absorption-based spectroscopic technique to the sample to obtain spectrum data whose spectral profile has been influenced by exposing the sample to the antibiotic, wherein applying the absorption-based spectroscopic technique to the sample includes irradiating the sample with UV-Vis radiation having a wavelength in the range 200nm to 800 nm; obtaining information regarding the susceptibility/resistance of the bacterium of interest to the antibiotic from the spectrum data; wherein the absorption-based spectroscopic technique is applied to the sample no more than 60 minutes after the initial exposure of the sample to the antibiotic.
A flow sensing valve, comprising: a valve housing including an inlet port, an outlet port, and a plurality of flow sensing ports (208, 210), wherein the inlet port and the outlet port are in fluid communication with a flow of pressurized fuel in an upstream manifold; a valve member located within the valve housing, wherein the valve member is configured to move between an open position and a closed position, wherein the valve member allows fuel flow between the inlet port and the outlet port in the open position, and wherein the valve member blocks fuel flow between the inlet port and the outlet port in the closed position; and a position sensor operably coupled to the valve member and configured to determine a valve position of the flow sensing valve, wherein the valve position is indicative of a valve open port area, and wherein a metered flow rate of pressurized fuel through the flow sensing valve is proportional to the valve open port area. a valve housing including an inlet port, an outlet port, and a plurality of flow sensing ports (208, 210), wherein the inlet port and the outlet port are in fluid communication with a flow of pressurized fuel in an upstream manifold; a valve member located within the valve housing, wherein the valve member is configured to move between an open position and a closed position, wherein the valve member allows fuel flow between the inlet port and the outlet port in the open position, and wherein the valve member blocks fuel flow between the inlet port and the outlet port in the closed position; and a position sensor operably coupled to the valve member and configured to determine a valve position of the flow sensing valve, wherein the valve position is indicative of a valve open port area, and wherein a metered flow rate of pressurized fuel through the flow sensing valve is proportional to the valve open port area.